<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46-pharmaceuticals-13-00233">
 <label>46.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lazar</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Ditu</surname>
    <given-names>L.-M.</given-names>
   </name>
   <name>
    <surname>Pircalabioru</surname>
    <given-names>G.G.</given-names>
   </name>
   <name>
    <surname>Gheorghe</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Curutiu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Holban</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Picu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Petcu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chifiriuc</surname>
    <given-names>M.C.</given-names>
   </name>
  </person-group>
  <article-title>Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer</article-title>
  <source>Front. Immunol.</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>1830</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2018.01830</pub-id>
  <?supplied-pmid 30158926?>
  <pub-id pub-id-type="pmid">30158926</pub-id>
 </element-citation>
</ref>
